TB Alliance has announced the start of the first human trial of a new tuberculosis (TB) drug candidate, designated TBA-354. It is the first new TB drug candidate to begin a Phase 1 clinical trial ...
Mumbai: Pharma major Lupin Limited has announced a strategic collaboration with TB Alliance, a nonprofit drug developer, to ...
Lupin partners with TB Alliance to develop and commercialize Telacebec for treating tuberculosis and related diseases globally.
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...
Global pharmaceutical major Lupin Limited has entered into a strategic collaboration with TB Alliance to advance the clinical development and commercialization of the investigational drug Telacebec, ...
Lupin and TB Alliance join forces to advance Telacebec to treat tuberculosis and other mycobacterial diseases: Our Bureau, Mumbai Monday, February 2, 2026, 13:45 Hrs [IST] Global ...
NEW YORK, Feb. 23, 2023 /PRNewswire/ -- The TB Alliance Board of Directors has elected David Norton as Chairperson of the Board. In this role, David will provide leadership to a diverse Board ...
NEW YORK, Jan. 15, 2019 /PRNewswire/ -- TB Alliance, a not-for-profit organization dedicated to developing new drug regimens to fight tuberculosis (TB), has appointed Dr. Jan Lundberg to its Board of ...
First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB TB Alliance and its ...
NC-009 pan-phase 2 clinical trial to evaluate the safety and efficacy of a combination of TBAJ-876, pretomanid and linezolid for its potential to shorten and improve treatment for both drug-sensitive ...
NEW YORK, June 25, 2019 /PRNewswire/ -- TB Alliance today announced the appointment of Eugene Sun, MD to the position of Senior Vice President for Research and Development. Dr. Sun will oversee TB ...